Gammaglobulin is generally referred to as intravenous human immunoglobulin (pH4), and its main effect is to treat primary immunoglobulin deficiency, secondary immunoglobulin deficiency disease, and autoimmune diseases.
Common side effects include headache, chills, fever, malaise, back pain, nausea, vomiting, abdominal pain, diarrhea, infusion site reactions, hypertension, hypotension, and tachycardia.
Intravenous human immunoglobulin (pH4) contains broad-spectrum anti-viral, bacterial or other pathogens igg antibody, the unique type of immunoglobulin and the unique type of antibody can form a complex immune network, so it has the dual therapeutic effect of immune replacement and immune regulation. After intravenous infusion, it can rapidly increase the level of igg in the recipient’s blood and enhance the body’s anti-infection ability and immune regulation function.
It is contraindicated in patients who are allergic to human immunoglobulin or have a history of other severe allergies, in selective iga-deficient patients with anti-iga antibodies, and should be used with caution in women who are known to be or may become pregnant, and the use of the drug in children and the elderly is not yet clear.
If you need to use intravenous human immunoglobulin (pH4), it is recommended that you consult a medical professional and follow the doctor’s instructions to regulate the use of medication.